Thomas Nittoli

955 total citations
21 papers, 738 citations indexed

About

Thomas Nittoli is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thomas Nittoli has authored 21 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thomas Nittoli's work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Chemical Synthesis and Analysis (4 papers). Thomas Nittoli is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Chemical Synthesis and Analysis (4 papers). Thomas Nittoli collaborates with scholars based in United States and Canada. Thomas Nittoli's co-authors include Scott McN. Sieburth, Luxuan Guo, Russell G. Dushin, M. Brawner Floyd, Allan Wissner, Frank J. Delfino, Marcus P. Kelly, Arthur Kunz, Julian Andreev and Gavin Thurston and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer Research.

In The Last Decade

Thomas Nittoli

21 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Nittoli United States	13	388	266	207	134	74	21	738
Brad O. Buckman United States	19	407 1.0×	391 1.5×	169 0.8×	75 0.6×	21 0.3×	37	986
B. Veerendra India	10	399 1.0×	123 0.5×	216 1.0×	214 1.6×	37 0.5×	22	736
Daniel H. O’Donovan United Kingdom	16	301 0.8×	451 1.7×	138 0.7×	69 0.5×	30 0.4×	27	833
Tianbao Lu United States	20	415 1.1×	569 2.1×	332 1.6×	45 0.3×	21 0.3×	36	1.1k
Curtis Harwig Canada	17	332 0.9×	286 1.1×	199 1.0×	243 1.8×	44 0.6×	27	833
Claudio Mapelli United States	18	527 1.4×	594 2.2×	110 0.5×	47 0.4×	107 1.4×	32	1.2k
Gretchen M. Schroeder United States	15	898 2.3×	377 1.4×	307 1.5×	233 1.7×	303 4.1×	26	1.4k
Maurice M. Morelock United States	19	125 0.3×	384 1.4×	162 0.8×	140 1.0×	51 0.7×	26	888
Robert H. Berndsen Netherlands	10	282 0.7×	206 0.8×	356 1.7×	30 0.2×	53 0.7×	11	640
Federica Pisaneschi United States	16	324 0.8×	255 1.0×	124 0.6×	107 0.8×	20 0.3×	51	702

Countries citing papers authored by Thomas Nittoli

Since Specialization

Citations

This map shows the geographic impact of Thomas Nittoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Nittoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Nittoli more than expected).

Fields of papers citing papers by Thomas Nittoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Nittoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Nittoli. The network helps show where Thomas Nittoli may publish in the future.

Co-authorship network of co-authors of Thomas Nittoli

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Nittoli. A scholar is included among the top collaborators of Thomas Nittoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Nittoli. Thomas Nittoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kelly, Marcus P., Sosina Makonnen, Carlos Hickey, et al.. (2021). Abstract P134: Novel EGFRvIII-selective antibody-drug conjugate REGN3124-PBD is strongly efficacious against orthotopic glioblastoma multiforme patient derived xenografts. Molecular Cancer Therapeutics. 20(12_Supplement). P134–P134. 1 indexed citations

Nittoli, Thomas, Frank J. Delfino, Marcus P. Kelly, et al.. (2020). Antibody drug conjugates of cleavable amino-benzoyl-maytansinoids. Bioorganic & Medicinal Chemistry. 28(23). 115785–115785. 4 indexed citations

Bay, Andrés E. Perez, Anuj Kalsy, Bo Luan, et al.. (2019). Abstract 233: Bispecific HER2 ADC: Making more potent HER2 ADC by improving target internalization. 233–233. 1 indexed citations

Bay, Andrés E. Perez, Anuj Kalsy, Zhaoyuan Chen, et al.. (2019). Abstract 233: Bispecific HER2 ADC: Making more potent HER2 ADC by improving target internalization. Cancer Research. 79(13_Supplement). 233–233. 3 indexed citations

Kelly, Marcus P., Carlos Hickey, Sosina Makonnen, et al.. (2017). Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody–Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers. Molecular Cancer Therapeutics. 16(7). 1299–1311. 19 indexed citations

Andreev, Julian, Andrés E. Perez Bay, Frank J. Delfino, et al.. (2017). Bispecific Antibodies and Antibody–Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs. Molecular Cancer Therapeutics. 16(4). 681–693. 129 indexed citations

Zapf, Christoph W., Jonathan D. Bloom, Russell G. Dushin, et al.. (2011). Macrocyclic lactams as potent Hsp90 inhibitors with excellent tumor exposure and extended biomarker activity. Bioorganic & Medicinal Chemistry Letters. 21(11). 3411–3416. 14 indexed citations

Zapf, Christoph W., Jonathan D. Bloom, Zhong Li, et al.. (2011). Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model. Bioorganic & Medicinal Chemistry Letters. 21(15). 4602–4607. 24 indexed citations

Zapf, Christoph W., Jonathan D. Bloom, Russell G. Dushin, et al.. (2011). Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity. Bioorganic & Medicinal Chemistry Letters. 21(8). 2278–2282. 18 indexed citations

10.

Dushin, Russell G., Thomas Nittoli, Diane H. Boschelli, et al.. (2009). Synthesis and PKCθ inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitriles. Bioorganic & Medicinal Chemistry Letters. 19(9). 2461–2463. 20 indexed citations

11.

Nittoli, Thomas, Russell G. Dushin, M. Brawner Floyd, et al.. (2009). The identification of 8,9-dimethoxy-5-(2-aminoalkoxy-pyridin-3-yl)-benzo[c][2,7]naphthyridin-4-ylamines as potent inhibitors of 3-phosphoinositide-dependent kinase-1 (PDK-1). European Journal of Medicinal Chemistry. 45(4). 1379–1386. 21 indexed citations

12.

Wissner, Allan, Russell G. Dushin, M. Brawner Floyd, et al.. (2007). Dual irreversible kinase inhibitors: Quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2. Bioorganic & Medicinal Chemistry. 15(11). 3635–3648. 62 indexed citations

13.

Nittoli, Thomas, Kevin Curran, Martin DiGrandi, et al.. (2007). Identification of Anthranilic Acid Derivatives as a Novel Class of Allosteric Inhibitors of Hepatitis C NS5B Polymerase.. Journal of Medicinal Chemistry. 50(24). 6290–6290. 3 indexed citations

14.

Nittoli, Thomas, Kevin J. Curran, Martin DiGrandi, et al.. (2007). Identification of Anthranilic Acid Derivatives as a Novel Class of Allosteric Inhibitors of Hepatitis C NS5B Polymerase. Journal of Medicinal Chemistry. 50(9). 2108–2116. 42 indexed citations

15.

Nittoli, Thomas, et al.. (2002). Silicon-Based Metalloprotease Inhibitors: Synthesis and Evaluation of Silanol and Silanediol Peptide Analogues as Inhibitors of Angiotensin-Converting Enzyme¹. Journal of the American Chemical Society. 124(25). 7363–7375. 170 indexed citations

16.

Smith, Amos B., Thomas Nittoli, Paul A. Sprengeler, et al.. (2000). Design, Synthesis, and Evaluation of a Pyrrolinone-Based Matrix Metalloprotease Inhibitor. Organic Letters. 2(24). 3809–3812. 9 indexed citations

17.

Nittoli, Thomas, Scott McN. Sieburth, & Geoffrey M. Coast. (1999). Evidence for helicity in insect diuretic peptide hormones: computational analysis, spectroscopic studies, and biological assays. Journal of Peptide Research. 53(2). 99–108. 5 indexed citations

18.

Sieburth, Scott McN., et al.. (1998). Silanediols: A New Class of Potent Protease Inhibitors. Angewandte Chemie International Edition. 37(6). 812–814. 118 indexed citations

19.

Sieburth, Scott McN., et al.. (1998). ChemInform Abstract: Silanediols: A New Class of Potent Protease Inhibitors.. ChemInform. 29(28). 4 indexed citations

20.

Sieburth, Scott McN., et al.. (1998). Silandiole: eine neue Klasse potenter Protease-Inhibitoren. Angewandte Chemie. 110(6). 845–847. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact